Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 2
1952 6
1953 3
1954 6
1955 11
1956 15
1957 13
1958 3
1959 4
1960 4
1961 11
1962 14
1963 19
1964 19
1965 19
1966 24
1967 39
1968 39
1969 43
1970 45
1971 43
1972 44
1973 47
1974 44
1975 57
1976 50
1977 43
1978 48
1979 51
1980 52
1981 66
1982 86
1983 92
1984 91
1985 98
1986 100
1987 123
1988 128
1989 144
1990 122
1991 130
1992 123
1993 138
1994 185
1995 159
1996 177
1997 191
1998 189
1999 220
2000 194
2001 221
2002 205
2003 257
2004 252
2005 296
2006 323
2007 303
2008 313
2009 336
2010 332
2011 376
2012 375
2013 384
2014 334
2015 364
2016 321
2017 369
2018 365
2019 375
2020 473
2021 501
2022 509
2023 431
2024 456
2025 435
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,501 results

Results by year

Filters applied: . Clear all
Page 1
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.
Mountzios G, Sun L, Cho BC, Demirci U, Baka S, Gümüş M, Lugini A, Zhu B, Yu Y, Korantzis I, Han JY, Ciuleanu TE, Ahn MJ, Rocha P, Mazières J, Lau SCM, Schuler M, Blackhall F, Yoshida T, Owonikoko TK, Paz-Ares L, Jiang T, Hamidi A, Gauto D, Recondo G, Rudin CM; DeLLphi-304 Investigators. Mountzios G, et al. Among authors: yoshida t. N Engl J Med. 2025 Jul 24;393(4):349-361. doi: 10.1056/NEJMoa2502099. Epub 2025 Jun 2. N Engl J Med. 2025. PMID: 40454646 Clinical Trial.
Schizophrenia and cognitive dysfunction.
Takeda T, Umehara H, Matsumoto Y, Yoshida T, Nakataki M, Numata S. Takeda T, et al. Among authors: yoshida t. J Med Invest. 2024;71(3.4):205-209. doi: 10.2152/jmi.71.205. J Med Invest. 2024. PMID: 39462553 Free article. Review.
The subfornical organ is a nucleus for gut-derived T cells that regulate behaviour.
Yoshida TM, Nguyen M, Zhang L, Lu BY, Zhu B, Murray KN, Mineur YS, Zhang C, Xu D, Lin E, Luchsinger J, Bhatta S, Waizman DA, Coden ME, Ma Y, Israni-Winger K, Russo A, Wang H, Song W, Al Souz J, Zhao H, Craft JE, Picciotto MR, Grutzendler J, Distasio M, Palm NW, Hafler DA, Wang A. Yoshida TM, et al. Nature. 2025 Jul;643(8071):499-508. doi: 10.1038/s41586-025-09050-7. Epub 2025 May 28. Nature. 2025. PMID: 40437096
Left atrial single-cell transcriptomics reveals amphiregulin as a surrogate marker for atrial fibrillation.
Suzuki Y, Emoto T, Sato S, Yoshida T, Shoda M, Endoh H, Nagao M, Hamana T, Inoue T, Hayashi T, Nitta E, Konishi H, Kiuchi K, Takami M, Imamura K, Taniguchi M, Inoue M, Nakamura T, Sonoda Y, Takahara H, Nakasone K, Yamamoto K, Tani K, Iwai H, Nakanishi Y, Yonehara S, Murakami A, Toh R, Ohkawa T, Furuyashiki T, Nitta R, Yamashita T, Hirata KI, Fukuzawa K. Suzuki Y, et al. Among authors: yoshida t. Commun Biol. 2024 Dec 2;7(1):1601. doi: 10.1038/s42003-024-07308-w. Commun Biol. 2024. PMID: 39622943 Free PMC article.
Assessing inspiratory drive and effort in critically ill patients at the bedside.
Tonelli R, Protti A, Spinelli E, Grieco DL, Yoshida T, Jonkman AH, Akoumianaki E, Telias I, Docci M, Rodrigues A, Perez J, Piquilloud L, Beitler J, Liu L, Roca O, Pisani L, Goligher E, Carteaux G, Bellani G, Clini E, Zhou JX, Grasselli G, Jaber S, Demoule A, Talmor D, Heunks L, Brochard L, Mauri T. Tonelli R, et al. Among authors: yoshida t. Crit Care. 2025 Jul 31;29(1):339. doi: 10.1186/s13054-025-05526-0. Crit Care. 2025. PMID: 40745324 Free PMC article. Review.
First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trial.
Lee KH, Lee JS, Sugawara S, Kang JH, Kim HR, Inui N, Hida T, Yoshida T, Tanaka H, Yang CT, Inoue T, Nishio M, Ohe Y, Tamura T, Yamamoto N, Yu CJ, Akamatsu H, Takahashi S, Nakagawa K. Lee KH, et al. Among authors: yoshida t. Lung Cancer. 2025 Mar;201:108109. doi: 10.1016/j.lungcan.2025.108109. Epub 2025 Jan 25. Lung Cancer. 2025. PMID: 39893774 Free article. Clinical Trial.
11,501 results
You have reached the last available page of results. Please see the User Guide for more information.